Enfermedades del segmento anterior del ojo de las personas con trisomía 21

Página de inicio
Contenidos
Enfermedades del segmento anterior del ojo de las personas con trisomía 21

Página de inicio
Contenidos
Enfermedades del segmento anterior del ojo de las personas con trisomía 21

13 Jun 2023

Médica y paramédica

PATOLOGÍAS OFTALMOLÓGICAS

Enfermedades del segmento anterior del ojo

ESQUEMA DEL CAPÍTULO

1- El ojo y la vision

2- Otras enfermedades del ojo

3- Trastornos de la vision

4- Patologías del segmento anterior del ojo

5- Patologías del segmento posterior del ojo

6- Neuro-oftalmología

Es probable que el iris, la córnea y el cristalino se vean afectados por anomalías en las personas con trisomía 21. Es necesaria una mayor observación, tanto en niños como en adultos, para garantizar un tratamiento más eficaz.

El Dr. Hervé Walti, pediatra del Instituto Jérôme Lejeune, nos habla de estas patologías del segmento anterior del ojo en el siguiente vídeo y en la ficha informativa que lo acompaña. Para consultar el capítulo completo, haga clic en los enlaces situados a la derecha de la página.

Descubra a continuación la presentación asociada a este vídeo sobre el tema “Patologías oftalmológicas”.

Akoto T, Li JJ, Estes AJ, Karamichos D, Liu Y. The Underlying Relationship between Keratoconus and Down Syndrome. Int J Mol Sci. 2022 Sep 16;23(18):10796.
Alio JL, Vega-Estrada A, Sanz P, Osman AA, Kamal AM, Mamoon A, Soliman H. Corneal Morphologic Characteristics in Patients With Down Syndrome. JAMA Ophthalmol. 2018 Sep 1;136(9):971-978.
Asgari S, Aghamirsalim M, Mehravaran S, Hashemi H. Effect of Down syndrome and keratoconus on corneal density and volume: a triple comparative study. Sci Rep. 2020a Jun 4;10(1):9098.
Asgari S, Hashemi H, Fotouhi A, Mehravaran S. Anterior chamber dimensions, angles and pupil diameter in patients with Down syndrome: A comparative population-based study. Indian J Ophthalmol. 2020b May;68(5):793-797.
Aslan L, Aslankurt M, Aksoy A, Gümüşalan Y. Differences of the anterior segment parameters in children with down syndrome. Ophthalmic Genet. 2014 Jun;35(2):74-8.
Bei L, Shui YB, Bai F, Nelson SK, Van Stavern GP, Beebe DC. A test of lens opacity as an indicator of preclinical Alzheimer Disease. Exp Eye Res. 2015 Nov;140:117-123.
Bromham NR, Woodhouse JM, Cregg M, Webb E, Fraser WI. Heart defects and ocular anomalies in children with Down’s syndrome. Br J Ophthalmol. 2002 Dec;86(12):1367-8.
Brushfield, T. Mongolism. Brit. J. Child. Dis. 21, 241–258 (1924).
Bull MJ, Trotter T, Santoro SL, Christensen C, Grout RW; COUNCIL ON GENETICS, Burke LW, Berry SA, Geleske TA, Holm I, Hopkin RJ, Introne WJ, Lyons MJ, Monteil DC, Scheuerle A, Stoler JM, Vergano SA, Chen E, Hamid R, Downs SM, Grout RW, Cunniff C, Parisi MA, Ralston SJ, Scott JA, Shapira SK, Spire P. Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics. 2022 May 1;149(5):e2022057010.
Fimiani F, Iovine A, Carelli R, Pansini M, Sebastio G, Magli A. Incidence of ocular pathologies in Italian children with Down syndrome. Eur J Ophthalmol. 2007 Sep-Oct;17(5):817-22.
Fong AH, Shum J, Ng AL, Li KK, McGhee S, Wong D. Prevalence of ocular abnormalities in adults with Down syndrome in Hong Kong. Br J Ophthalmol. 2013 Apr;97(4):423-8.
Gardiner C, Lanigan B, O’Keefe M. Postcataract surgery outcome in a series of infants and children with Down syndrome. Br J Ophthalmol. 2008 Aug;92(8):1112-6.
Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP. Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study. Am J Ophthalmol. 2017 Mar;175:169-172
Haargaard B, Fledelius HC. Down’s syndrome and early cataract. Br J Ophthalmol. 2006 Aug;90(8):1024-7.
Hammer A, Tabibian D, Richoz O, Hafezi F. Prise en charge du kératocône par cross-linking du collagène cornéen [Keratoconus treatment by corneal cross-linking (CLX)]. Rev Med Suisse. 2014 Jun 4;10(433):1263-5. French.
Haseeb A, Huynh E, ElSheikh RH, ElHawary AS, Scelfo C, Ledoux DM, Maidana DE, Elhusseiny AM. Down syndrome: a review of ocular manifestations. Ther Adv Ophthalmol. 2022 Jun 30;14:25158414221101718.
Hashemi H, Miraftab M, Amanzadeh K, Seyedian MA, Vinciguerra R, Ambrósio R Jr, Roberts C, Makateb A, Vinciguerra P, Asgari S. Keratoconus detection by novel indices in patients with Down syndrome: a cohort population-based study. Jpn J Ophthalmol. 2020aMay;64(3):285-291.
Hashemi H, Amanzadeh K, Seyedian M, Zeraati H, Roberts CJ, Mehravaran S, Ambrósio R Jr, Vinciguerra R, Vinciguerra P, Asgari S. Accelerated and Standard Corneal Cross-Linking Protocols in Patients with Down Syndrome: A Non-inferiority Contralateral Randomized Trial. Ophthalmol Ther. 2020b Dec;9(4):1011-1021.
Hashemi H, Asgari S. Corneal characteristics in Down syndrome patients with normal and keratoconic cornea. Front Med (Lausanne). 2022 Sep 16;9:985928.
Haugen OH, Høvding G, Eide GE. Biometric measurements of the eyes in teenagers and young adults with Down syndrome. Acta Ophthalmol Scand. 2001 Dec;79(6):616-25.
Jaeger EA. Ocular findings in Down’s syndrome. Trans Am Ophthalmol Soc. 1980;78:808-45.
Khokhar S, Banerjee M, Raj SJS, Sandhu S. Atypical morphological variants of congenital cataract in Down’s syndrome. BMJ Case Rep. 2021 May 7;14(5):e242759.
Kim JH, Hwang JM, Kim HJ, Yu YS. Characteristic ocular findings in Asian children with Down syndrome. Eye (Lond). 2002 Nov;16(6):710-4.
Krinsky-McHale SJ, Jenkins EC, Zigman WB, Silverman W. Ophthalmic disorders in adults with down syndrome. Curr Gerontol Geriatr Res. 2012;2012:974253.
Kristianslund O, Drolsum L. Prevalence of Keratoconus in Persons With Down Syndrome in a National Registry in Norway. JAMA Netw Open. 2021 Mar 1;4(3):e210814.
Li EY, Chan TC, Lam NM, Jhanji V. Cataract surgery outcomes in adult patients with Down’s syndrome. Br J Ophthalmol. 2014 Sep;98(9):1273-6.

Li X, Si N, Song Z, Ren Y, Xiao W. Clinical and genetic findings in patients with congenital cataract and heart diseases. Orphanet J Rare Dis. 2021 May 31;16(1):242.
Little JA, Mahil AS, Richardson P, Woodhouse JM, Vinuela-Navarro V, Saunders KJ. In-vivo anterior segment OCT imaging provides unique insight into cerulean blue-dot opacities and cataracts in Down syndrome. Sci Rep. 2020 Jun 22;10(1):10031.
Liza-Sharmini AT, Azlan ZN, Zilfalil BA. Ocular findings in Malaysian children with Down syndrome. Singapore Med J. 2006 Jan;47(1):14-9.
Maharana PK, Sharma N, Vajpayee RB. Acute corneal hydrops in keratoconus. Indian J Ophthalmol. 2013 Aug;61(8):461-4.
Mathan JJ, Simkin SK, Gokul A, McGhee CNJ. Down syndrome and the eye: Ocular characteristics and ocular assessment. Surv Ophthalmol. 2022 Apr 1:S0039-6257(22)00043-1.
Moncaster JA, Pineda R, Moir RD, Lu S, Burton MA, Ghosh JG, Ericsson M, Soscia SJ, Mocofanescu A, Folkerth RD, Robb RM, Kuszak JR, Clark JI, Tanzi RE, Hunter DG, Goldstein LE. Alzheimer’s disease amyloid-beta links lens and brain pathology in Down syndrome. PLoS One. 2010 May 20;5(5):e10659.
Moncaster JA, Moir RD, Burton MA, Chadwick O, Minaeva O, Alvarez VE, Ericsson M, Clark JI, McKee AC, Tanzi RE, Goldstein LE. Alzheimer’s disease amyloid-β pathology in the lens of the eye. Exp Eye Res. 2022 Aug;221:108974.
Muñoz-Ortiz J, Charry-Sánchez JD, Bechara-Arango I, Blanco-Becerra M, Talero-Gutiérrez C, Gomez-Suarez M, de-la-Torre A. Down syndrome: a systematic review Prevalence of ophthalmological manifestations in pediatric and adolescent populations with of the literature. Syst Rev. 2022 Apr 22;11(1):75.
Ozcan AA, Ersoz TR. Severe acute corneal hydrops in a patient with Down syndrome and persistent eye rubbing. Ann Ophthalmol (Skokie). 2007 Spring;39(2):158-60.
PNDS : Protocole National de Diagnostic et de Soins Keratocône , HAS 2021
Postolache L, Parsa CF. Brushfield spots and Wölfflin nodules unveiled in dark irides using near-infrared light. Sci Rep. 2018 Dec 21;8(1):18040.
Puri BK, Singh I. Prevalence of cataract in adult Down’s syndrome patients aged 28 to 83 years. Clin Pract Epidemiol Ment Health. 2007 Nov 22;3:26.
Rahi JS, Dezateux C. Congenital and infantile cataract in the United Kingdom: underlying or associated factors. British Congenital Cataract Interest Group. Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2108-14.
Saifee M, Kong L, Yen KG. Outcomes of Cataract Surgery in Children with Down Syndrome. J Ophthalmic Vis Res. 2017 Apr-Jun;12(2):243-244.
Santoro SL, Atoum D, Hufnagel RB, Motley WW. Surgical, medical and developmental outcomes in patients with Down syndrome and cataracts. SAGE Open Med. 2017 Jun 19;5:2050312117715583.
Shapiro MB, France TD. The ocular features of Down’s syndrome. Am J Ophthalmol. 1985 Jun 15;99(6):659-63.
Sharma R, Shankar S, Kumar N, Vichhare N. Immediately sequential bilateral cataract surgery in Down syndrome. Indian J Ophthalmol. 2022 Nov;70(11):4089-4091.
Sheeladevi S, Lawrenson JG, Fielder AR, Suttle CM. Global prevalence of childhood cataract: a systematic review. Eye (Lond). 2016 Sep;30(9):1160-9.
Skeller E, Øster J. Eye symptoms in mongolism. Acta Ophthalmol (Copenh). 1951;29(2):149-61.
Tătaru CI, Voinea LM, Tătaru CP, Sima G. Clinical and therapeutic particularities of congenital cataracts in pediatric patients with Down syndrome. Rom J Ophthalmol. 2020 Apr-Jun;64(2):168-175.
Toprak I, Cavas F, Vega A, Velázquez JS, Alio Del Barrio JL, Alio JL. Evidence of a Down Syndrome Keratopathy: A Three-Dimensional (3-D) Morphogeometric and Volumetric Analysis. J Pers Med. 2021 Jan 30;11(2):82.
Traboulsi EI, Levine E, Mets MB, Parelhoff ES, O’Neill JF, Gaasterland DE. Infantile glaucoma in Down’s syndrome (trisomy 21). Am J Ophthalmol. 1988 Apr 15;105(4):389-94.
Wong V, Ho D. Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children. Pediatr Neurol. 1997 May;16(4):311-4.
Woodward MA, Blachley TS, Stein JD. The Association Between Sociodemographic Factors, Common Systemic Diseases, and Keratoconus: An Analysis of a Nationwide Heath Care Claims Database. Ophthalmology. 2016 Mar;123(3):457-65.e2.
Yokoyama T, Tamura H, Tsukamoto H, Yamane K, Mishima HK. Prevalence of glaucoma in adults with Down’s syndrome. Jpn J Ophthalmol. 2006 May-Jun;50(3):274-6.